Medtronic (MDT) came out with quarterly earnings of $1.30 per share, beating the Zacks Consensus Estimate of $1.26 per share. This compares to earnings of $1.30 per share a year ago. These figures are adjusted for non- recurring items. This quarterly report represents an earnings surprise of 3.17%. A quarter ago, it was expected that this medical device company would post earnings of $1.18 per share when it actually produced earnings of $1.25, delivering a surprise of 5.93%. Over the last four quarters, the ...

SOPA Images/LightRocket via Getty Images Introduction Medical devices remain a very stable business within the healthcare sector, even in times of economic uncertainty. Medical devices can be a suitable investment with fluctuating markets and economic cycles due to macro data that postpone the anticipated interest rate decrease. This segment is stable due to the constant demand for market medical procedures, thus making it more stable. I believe companies within this b sector that lead innovation are partic ...

公司业务 - Medtronic是一家全球领先的医疗技术和解决方案公司，产品专注于管理心脏节律、脊柱和手术导航进步、糖尿病和神经系统疾病的治疗、血管治疗以及心脏手术等领域[2] - Medtronic的多元化业务布局和全球产品分销使其业务结构更加强大，有助于降低地理集中风险[9] 财务表现 - Medtronic的财务表现在过去十年从营收增长的角度来看表现稳健，年复合增长率为7.1%[4] - 利润率近年来已经稳定，并且在一个相对狭窄的范围内波动，这大大降低了管理层和投资者的不确定性水平[4] 资产负债表 - 截至最新报告日期，Medtronic拥有77亿美元的现金和谨慎的杠杆比率，为公司提供了巨大的财务灵活性[5] - Medtronic在过去十年中进行了总计230亿美元的现金收购投资，占同期累计营业利润的40%左右，为其可持续增长提供了更多机会[5] 股票分析 - 根据DDM分析，Medtronic的股票公平价值为92.4美元，代表了10%的上涨潜力[13] - 根据DCF模拟，Medtronic的业务公平价值约为1230亿美元，比当前市值高出10%[16] 评级展望 - Medtronic股票被评为“买入”，公司展现出保持强劲营收增长的潜力，管理层专注于提高盈利能力对于构建持久的股东价值至关重要[21]

股价表现 - Medtronic (MDT) 最新收盘价为 $83.68，较前一个交易日上涨了 +0.11% [1] - Medtronic 过去一个月的股价下跌了 3.41%，落后于医疗行业的涨幅 1.18% 和标普500指数的涨幅 3.69% [2] 财务预测 - 投资界将密切关注 Medtronic 即将发布的财报，预计每股收益为 $1.26，较去年同期下降了 3.08%，预计营收为 $7.95 亿美元，较去年同期上涨了 2.91% [3] - 根据 Zacks Consensus Estimates，分析师预计 Medtronic 全年每股收益为 $5.16，营收为 $320.7 亿美元，较去年分别下降了 2.46% 和上涨了 2.71% [4] 估值分析 - 从估值角度看，Medtronic 目前的前瞻市盈率为 16.19，较行业平均前瞻市盈率 20 有折价 [7] - MDT 目前的 PEG 比率为 2.92，考虑了股票预期的盈利增长率，医疗产品行业的平均 PEG 比率为 2.37 [8] 行业排名 - 医疗产品行业属于医疗领域，目前的 Zacks Industry Rank 为 162，在所有 250+ 个行业中处于倒数 36% [9] - Zacks Industry Rank 通过确定组成行业的个别股票的平均 Zacks Rank 来评估我们独特行业群体的实力，研究显示，排名前50%的行业的表现是底部一半的两倍 [10] 评级和展望 - 分析师对 Medtronic 的最新估值变动表明，这些修订通常反映了最新的短期业务趋势，积极的修订表明分析师对公司的业务和盈利能力持乐观态度 [5] - Zacks Rank 模型考虑这些估值变动并提供可操作的评级系统，目前 Medtronic 的 Zacks Rank 为 3 (Hold) [6]

财报预测 - 华尔街分析师预计Medtronic将在即将发布的季度报告中宣布每股收益为1.26美元，同比下降3.1%[1] - 预计营收将达到795亿美元，同比增长2.9%[1] - 在过去30天内，对本季度的共识每股收益预期没有进行修订[2] - 分析师在此期间对其最初的预测进行了集体重新考虑[2] 收益预测修订 - 重要的是要考虑收益预测的任何变化[3] - 修订在预测投资者对股票的可能反应方面起着至关重要的作用[3] - 多个实证研究一直显示，收益预测的趋势与股票的短期价格波动之间存在着强烈的关联[3]

Medtronic plc (MDT) is scheduled to report third-quarter fiscal 2024 results on Feb 20, before the opening bell. In the last reported quarter, the company’s earnings exceeded the Zacks Consensus Estimate by 5.9%. Medtronic surpassed estimates in three of the trailing four quarters and missed once, the average surprise being 4.46%. Let’s see how things have shaped up prior to this announcement. Factors at Play Similar to the last few quarters, Medtronic's business is expected to have registered growth. The u ...

股价表现 - Medtronic (MDT) 最新交易日收盘价为$86.18，较前一日下跌了1.12% [1] - Medtronic 过去一个月的股价上涨了0.09%，落后于医疗行业的3.52%和标普500指数的6.45% [2] 财务预测 - Medtronic 即将发布的财报备受投资者关注，预计将于2024年2月20日发布。预计每股收益为$1.26，较去年同期下降了3.08%。目前的市场预期收入为795亿美元，较去年同期增长了2.91% [3] - 根据Zacks Consensus Estimates，整个财年的预计每股收益为5.16美元，营收为320.7亿美元，分别较去年变化了-2.46%和+2.71% [4] 分析师预测 - 投资者应注意最近对Medtronic的分析师预测的变化，这些修订通常反映了最新的短期业务趋势 [5] - 研究表明，这些预测变化与未来股价表现直接相关，Zacks Rank模型考虑了这些预测变化并提供了可操作的评级系统 [6] 股票评级 - Zacks Rank系统从1（强烈买入）到5（强烈卖出），自1988年以来，排名第一的股票年均回报率为+25% [7] - Medtronic目前的Zacks Rank为3（持有） [7] 估值指标 - 目前，Medtronic的前瞻市盈率为16.88，行业平均前瞻市盈率为20.85，意味着Medtronic的股价折价于行业 [8] - MDT目前的PEG比率为3.05，该比率考虑了公司预期的盈利增长率 [9] 行业排名 - 医疗产品行业属于医疗行业，目前的Zacks Industry Rank为169，位于所有250多个行业的底部33% [10] - Zacks Industry Rank通过计算组内个股的平均Zacks Rank来评估各行业群体的实力 [11] 其他信息 - 请继续关注Zacks.com以了解这些影响股价的指标，以及更多信息 [12]

DUBLIN, Feb. 6, 2024 /PRNewswire/ -- Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced that it will report financial results for its third quarter of fiscal year 2024 on Tuesday, February 20, 2024. A news release will be issued at approximately 5:45 a.m. Central Standard Time (CST) and will be available at https://news.medtronic.com. The news release will include summary financial information for the company's third quarter of fiscal year 2024, which ended on Friday, Januar ...

In the latest trading session, Medtronic (MDT) closed at $86.75, marking a -1% move from the previous day. This move lagged the S&P 500's daily loss of 0.32%. At the same time, the Dow lost 0.71%, and the tech-heavy Nasdaq lost 0.2%. Prior to today's trading, shares of the medical device company had gained 3.62% over the past month. This has outpaced the Medical sector's gain of 2.33% and lagged the S&P 500's gain of 4.59% in that time. Analysts and investors alike will be keeping a close eye on the perform ...

股息股票 - 今天的股息股票在市场指数回到历史高位的情况下逐渐受到欢迎，许多高收入者和长期复利者被定价为折扣购买[1] - 房地产收入公司Realty Income (NYSE:O)因其股息贵族地位、每月分配和5.66%的收益率而成为永久的最爱[3] - AT&T (NYSE:T)定位为领先的增长型股息股票，推动着全球连接未来的边界，同时提供健康的6.48%总收益率[6]